Chrome Extension
WeChat Mini Program
Use on ChatGLM

Germline findings in patients with advanced malignancies screened with paired blood–tumour testing for personalised treatment approaches

European Journal of Cancer(2022)

Cited 0|Views60
No score
Abstract
•Significant amount of relevant germline variants is detected by blood-tumour testing.•Carriers do not always fulfil clinical criteria for cancer predisposition.•Blood–Tumour testing identifies novel links between cancer predisposition genes and cancer types.•Family-specific screening strategies are required when cancer predisposition genes are found in atypical tumours.
More
Translated text
Key words
Next-generation sequencing,Tumour–normal testing,Precision oncology,Personalised medicine,Cancer predisposition syndrome
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined